HormonesMelatonin

Dexmedetomidine-flurbiprofen axetil-based opioid-free analgesia improves postoperative sleep quality and attenuates melatonin suppression after thyroidectomy

In a randomized controlled trial of 96 patients undergoing thyroidectomy, an opioid-free PCIA regimen (dexmedetomidine, flurbiprofen axetil, ondansetron) significantly improved sleep quality (RCSQ scores, P<0.001) and preserved nocturnal melatonin secretion (urinary 6-SMT, P<0.001) compared to opioid-based PCIA (sufentanil, ondansetron). The opioid-free group also showed shorter sleep latency, fewer nocturnal awakenings, longer total sleep time, lower anxiety, and reduced opioid-related adverse events.

Last updated: Jul 28, 2026โ€ข1 RCTsโ€ข๐Ÿ“– Read as article โ†’

Evidence Score

Evidence Score42/100
Human RCTโ˜…โ˜…โ˜†โ˜†โ˜†
Meta-analysisโ˜†โ˜†โ˜†โ˜†โ˜†
Mechanismโ˜…โ˜…โ˜…โ˜…โ˜…
Safetyโ˜…โ˜…โ˜…โ˜…โ˜†
Confidencelow

Study Evidence

Study 1. Dexmedetomidine-flurbiprofen axetil-based opioid-free analgesia attenuates postoperative melatonin suppression and improves sleep quality after thyroidectomy: a randomized controlled trial.

observational

Guo R, Luo X, Chen L, Rao PG, Wang LF, Lei XH, Dai GY, Fang H ยท Frontiers in pharmacology (2026)

Participants: N/A
Duration: 48 hours postoperative
Intervention: Opioid-free PCIA with dexmedetomidine, flurbiprofen axetil, and ondansetron initiated 5 minutes before end of surgery
Outcome: Postoperative sleep quality (RCSQ), urinary 6-sulfatoxymelatonin excretion normalized to creatinine, sleep latency, nocturnal awakenings, total sleep time, anxiety levels
Effect Size: N/A
Population: 96 patients undergoing thyroidectomy

Result:

Mechanism Graph

Dexmedetomidine provides sedation and analgesia without opioid receptor activation
โ†“
Flurbiprofen axetil reduces inflammation and pain via COX inhibition
โ†“
Avoidance of opioids prevents suppression of nocturnal melatonin secretion
โ†“
Improved melatonin secretion leads to better sleep quality and reduced anxiety

Limitations

  • โš Single-center study with relatively small sample size (n=96)
  • โš Short follow-up limited to postoperative days 1 and 2, not assessing long-term sleep outcomes

Frequently Asked Questions

What is the primary benefit of opioid-free analgesia for sleep after thyroidectomy?โ–ผ

The opioid-free regimen based on dexmedetomidine and flurbiprofen axetil significantly improves sleep quality and preserves nocturnal melatonin secretion compared to opioid-based analgesia.

Does the opioid-free regimen provide adequate pain control?โ–ผ

Yes, postoperative pain intensity and sedation levels were comparable between the opioid-free and opioid groups at all measured time points.

What adverse events are reduced with opioid-free analgesia?โ–ผ

The incidences of nausea, vomiting, and pruritus were significantly reduced in the opioid-free group.

How was sleep quality measured in this study?โ–ผ

Sleep quality was assessed using the Richards-Campbell Sleep Questionnaire (RCSQ) and detailed sleep parameters including sleep latency, nocturnal awakenings, and total sleep time.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Guo R, Luo X, Chen L, Rao PG, Wang LF, Lei XH, Dai GY, Fang H. "Dexmedetomidine-flurbiprofen axetil-based opioid-free analgesia attenuates postoperative melatonin suppression and improves sleep quality after thyroidectomy: a randomized controlled trial.." Frontiers in pharmacology, 2026. PMID: 42465992 DOI: 10.3389/fphar.2026.1839440
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.